KSHN001034
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KSHN001034, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers [Phase 1]